Company Filing History:
Years Active: 2012-2017
Title: Young-Ki Paik: Innovator in Liver Cancer Diagnosis
Introduction
Young-Ki Paik is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of medical diagnostics, particularly in the early detection of liver cancer. With a total of 2 patents, his work focuses on innovative biomarker tools that enhance diagnostic accuracy.
Latest Patents
One of Young-Ki Paik's latest patents is a plasma biomarker tool for the diagnosis of liver cancer, specifically hepatocellular carcinoma (HCC). This invention involves the discovery of liver carboxylesterase 1 (hCE1) in human plasma, utilizing advanced techniques such as 2-D fluorescence differential gel electrophoresis (2-D DIGE), immunoprecipitation, and Nano-liquid chromatography mass spectrometry (Nano-LC-MS/MS). The presence of hCE1 is shown to be significantly higher in patients with HCC compared to healthy individuals, making it a valuable tool for early diagnosis.
Career Highlights
Throughout his career, Young-Ki Paik has worked with esteemed institutions, including Yonsei University and Jw Holdings Corporation. His research and innovations have positioned him as a key figure in the medical research community, particularly in the area of cancer diagnostics.
Collaborations
Young-Ki Paik has collaborated with notable colleagues, including Keun Na and Min Jung Lee. These partnerships have contributed to the advancement of his research and the development of his patented technologies.
Conclusion
Young-Ki Paik's innovative work in the field of liver cancer diagnosis exemplifies the impact of research and technology on healthcare. His contributions are paving the way for more effective screening methods, ultimately improving patient outcomes.